Scorpion Therapeutics

Boston, United States · Founded 2020 · $420.0M raised

Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$420.0M
Last Round
$150.0M Series CJul 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Scorpion Therapeutics is a clinical-stage precision oncology company developing transformational targeted therapies for patients with cancer. Founded in 2020, the company built a proprietary technology platform to identify and drug cancer-driving mutations. Its lead program STX-478, a mutant-selective PI3Kα inhibitor, was acquired by Eli Lilly in early 2025.

Summary

Scorpion Therapeutics is a Biotech company based in Boston, United States, founded in 2020. It has raised $420.0M in total across 3 rounds, most recently a $150.0M Series C round in Jul 2024. Investors include Atlas Venture, Vida Ventures and Frazier Life Sciences.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJul 2024
$150.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Scorpion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/scorpion-therapeutics"><img src="https://indexed.vc/api/badge/company/scorpion-therapeutics" alt="Scorpion Therapeutics on Indexed.vc" width="260" height="76" /></a>